Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Treat to Target in Psoriasis: A Real-World Experience With Biologics and Adjunctive Topical Therapy

By No Comments
The new treat-to-target goal for patients with plaque psoriasis – ≤ 1% of BSA involvement at 3 months after treatment initiation or 6 months of a maintenance regimen – has…
Read More
Dec 10
Love0

Depression? It’s the Disease NOT the Drug

By No Comments
Research into the immunopathological mechanisms of plaque psoriasis has produced increasingly targeted biologic therapies. The specificity of these agents allows for high rates of efficacy and decreased adverse events, most…
Read More
Dec 10
Love0

What Lies Beneath the Face Value of a BOX WARNING: A Deeper Look at Brodalumab

By No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated, inflammatory skin condition that affects 2-3% of the world’s population.1,2 Plaque psoriasis is the most common form of the disease, characterized by the presence of…
Read More
Dec 10
Love0

Lifting the Veil on Suicidal Ideation and Behavior in Psoriasis

By No Comments
Read More
Dec 10
Love0

Managing Seborrheic Keratosis: Evolving Strategies and Optimal Therapeutic Outcomes

By No Comments
INTRODUCTIONSeborrheic keratosis (SK) is one of the most common dermatologic lesions and is therefore the most common skin tumor seen by dermatologists in everyday practice 1. They are mostly benign,…
Read More
Dec 10
Love0

Evaluation of Men’s Trends and Experiences in Aesthetic Treatment

By No Comments
INTRODUCTIONThe number of men undergoing nonsurgical and surgical procedures has increased in recent years. According to the American Society for Aesthetic Plastic Surgery (ASAPS), nearly 1 in 10 cosmetic procedures…
Read More
Dec 10
Love0

Rheological Properties of Several Hyaluronic Acid-Based Gels: A Comparative Study

By No Comments
INTRODUCTIONFor over 23 years, hyaluronic acid (HA)-based gels have found application in esthetic medicine across the world as an optimal product to provide soft tissue augmentation, improve facial rejuvenation and…
Read More
Dec 10
Love0

The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review

By No Comments
BACKGROUNDThe Clostridium botulinum bacteria secretes 8 different exotoxins, called serotypes A-H.1,2 Serotype A is the most potent and is marketed under the brand name Botox ® (Allergan, Inc., Irvine, CA).…
Read More
Dec 10
Love0

Three-Dimensional Analysis of Minimally Invasive Vacuum-Assisted Subcision Treatment of Cellulite

By No Comments
INTRODUCTIONCellulite is commonly observed as a rippling or dimpling of the skin on the thighs and buttocks in as many as 80-90% of post-pubertal women1. Although multiple etiologies may exist,…
Read More
Dec 10
Love0

Assessing the Potential Role for Topical Melatonin in an Antiaging Skin Regimen

By No Comments
INTRODUCTIONMelatonin, the main neuroendocrine product of the pineal gland, is an endogenous hormone commonly associated with regulation of the sleep cycle. Exogenous melatonin, in the form of oral supplements, has…
Read More
Dec 10
Love0

A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma

By No Comments
INTRODUCTIONMelasma is a pigmentary condition in which patients de- velop symmetric, reticulated, hyperpigmented mac- ules and patches on the face.The disorder is thought to be the result of ultraviolet (UV)…
Read More
Dec 10
Love0

Clinical Efficacy of a Novel Two-Part Skincare System on Pollution-Induced Skin Damage

By No Comments
INTRODUCTIONIncreased awareness of the hazardous consequences of air pollution has led to global efforts to reduce air pollution and improve air quality. Air pollution is a serious issue for overall…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Tune in for the next podcast-style DermEdge episode May 12, 2026
  • Psoriatic Arthritis Awareness Month May 11, 2026
  • GLP-1 Therapies and Dermatology: A Brief Guide May 7, 2026
  • The Influence of Dermatologists’ Use of Social Media on Attracting Patients May 6, 2026
  • Podcast Refresher: Have You Listened To These Episodes? May 5, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram